CoChat

Strategies for prevention of scars: what can we learn from fetal skin?

Namazi, Mohammad Reza, Fallahzadeh, Mohammad Kazem, Schwartz, Robert A. · 2011 · International Journal of Dermatology
Cited by 145

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Fetal wound healing occurs rapidly and without scar formation early in gestation. Studying the mechanisms of scarless repair can lead to novel scar‐preventive approaches. In fetal wounds, collagen is deposited early and is fine and reticular with less cross‐linking. Several important differences of fetal vs. postgestational wound‐healing response have been determined, such as the presence of less inflammation, higher hyaluronic acid concentration and a greater ratio of collagen type III to type I. Compared with typical wounds, there are also altered ratios of signaling molecules, such as higher ratios of transforming growth factor (TGF)‐β3 to TGF‐β1 and ‐β2, and matrix metalloproteinases to tissue inhibitors of metalloproteinases. Furthermore, fetal fibroblasts do not exhibit TGF‐β1‐induced collagen production compared with their mature counterparts. Patterning genes (homeobox genes) involved in organogenesis are more active in the fetal period and are believed to be the “first domino” in the fetal cutaneous wound repair regulatory cascade. The recommended scar‐preventive agents, such as Scarguard MD®, silicone gel and sheet, Seprafilm® Bioresorbable Membrane, topical hyaluronan, onion extract, oral tamoxifen and 585‐nm pulsed dye laser are reviewed in this study. Despite the lack of supporting evidence, there is a widespread false presumption that the acceleration of healing with the widely assumed scar‐preventive commercial agents is associated with decreased scar formation. Humans are erroneously inclined to make a negative correlation between the healing rate and the degree of scar formation, while such a correlation does not exist in reality. Despite the importance of scar prevention, no FDA‐approved therapy for this purpose is available in the 21st century, which reflects the important challenges, such as the presence of redundant pathways, that these approaches are facing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-4632.2010.04678.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 145

Metadata

Authors
Namazi, M. R., Fallahzadeh, M. K., & Schwartz, R. A.
Venue
International Journal of Dermatology
Publisher
Wiley
Published
2010-10-06
Volume
50
Issue
1
Pages
85-93
ISSN
  • 0011-9059 (ISSN-L)
  • 1365-4632
OpenAlex
W2097560755
Cited by
145
References
1
FWCI
10.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies for prevention of scars: what can we learn from fetal skin? https://app.cochat.ai/papers/10.1111/j.1365-4632.2010.04678.x
The paper
Namazi, M. R., Fallahzadeh, M. K., & Schwartz, R. A. (2011). Strategies for prevention of scars: what can we learn from fetal skin? International Journal of Dermatology. https://doi.org/10.1111/j.1365-4632.2010.04678.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.